Advertisement

Topics

BRIEF—Opdivo gains approval in Australia for advanced bladder cancer

06:01 EST 15 Feb 2018 | thePharmaLetter

Immuno-oncology therapy Opdivo (nivolumab) has received registration by Australia’s Therapeutic Goods…

Original Article: BRIEF—Opdivo gains approval in Australia for advanced bladder cancer

NEXT ARTICLE

More From BioPortfolio on "BRIEF—Opdivo gains approval in Australia for advanced bladder cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...